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Abstract
The relationships between cerebrospinal fluid (CSF) and brain interstitial fluid are still being elucidated. It has been proposed 
that CSF within the subarachnoid space will enter paravascular spaces along arteries to flush through the parenchyma of 
the brain. However, CSF also directly exits the subarachnoid space through the cribriform plate and other perineural routes 
to reach the lymphatic system. In this study, we aimed to elucidate the functional relationship between CSF efflux through 
lymphatics and the potential influx into the brain by assessment of the distribution of CSF-infused tracers in awake and 
anesthetized mice. Using near-infrared fluorescence imaging, we showed that tracers quickly exited the subarachnoid space 
by transport through the lymphatic system to the systemic circulation in awake mice, significantly limiting their spread to 
the paravascular spaces of the brain. Magnetic resonance imaging and fluorescence microscopy through the skull under 
anesthetized conditions indicated that tracers remained confined to paravascular spaces on the surface of the brain. Immedi-
ately after death, a substantial influx of tracers occurred along paravascular spaces extending into the brain parenchyma. We 
conclude that under normal conditions a rapid CSF turnover through lymphatics precludes significant bulk flow into the brain.
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Introduction
The anatomical pathways and physiological mechanisms for 
the production, circulation and absorption of cerebrospinal 
fluid (CSF) and brain interstitial fluid (ISF) are currently an 
area of intense research focus. Historically, ISF is considered 
to be produced at the blood–brain barrier and to drain out 
of the brain towards the CSF [1, 14, 24, 53]. Pathways for a 
bulk flow of ISF from the brain parenchyma were found to 
be along peri-(or para-) vascular spaces (PVS) to reach the 
subarachnoid space (SAS) [13, 24, 53, 57] or along white 
matter fiber tracts to reach the ventricles [13, 46, 48]. How-
ever, several reports were published that ran counter to this 
view and suggested that a flow of CSF could occur from 
the SAS into the brain [8, 11, 40, 45, 52]. Of special note, 
Rennels et al. proposed a rapid CSF microcirculation to the 
brain with paravascular influx around arteries and efflux 
along veins. Although this concept was not fully accepted 
at the time [27], this work was recently cited as supporting 
evidence for a proposed glymphatic system of flow by Iliff 
et al. [29]. In experimental studies, tracers injected into the 
cisterna magna in mice were found with 2-photon imaging 
through a cranial window to enter the PVS around arteries 
penetrating into the cortex. At later time points tracers were 
also present in the PVS around veins. It was proposed that 
an astrocyte-facilitated convective flow existed through the 
parenchyma with influx along arteries and efflux along veins. 
Interestingly, this system was found to be more active dur-
ing sleeping or anesthetized conditions compared to awake 
conditions [54]. However, at this time, these studies remain 
highly controversial and several groups have challenged var-
ious aspects of the concept [1, 3, 5, 19, 21, 25, 26, 50, 51].
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While it is traditionally understood that CSF is absorbed 
mostly through arachnoid projections into the venous blood, 
we have recently demonstrated, using in vivo dynamic fluo-
rescence imaging, that bulk outflow of CSF occurs predomi-
nantly through the lymphatic system in mice [37]. The major 
CSF outflow pathways were found along cranial nerves (e.g., 
olfactory and optic) to reach lymphatic vessels outside the 
skull, consistent with many previous reports [10, 32, 33, 
39]. We have also demonstrated that lymphatic transport of 
interstitial fluid from skin and the peritoneal cavity is vastly 
increased during awake conditions compared to anesthetized 
conditions [44]. Therefore, it is of interest to determine how 
CSF outflow differs between awake and anesthetized mice 
and how these potential differences could influence the 
spread of CSF to the PVS of the brain. Thus, the first aim of 
the current study was to assess how lymphatic outflow from 
the CSF to the systemic blood is altered during awake condi-
tions compared to anesthetized conditions. We next aimed 
to determine whether the outflow of CSF was correlated 
with the spread of tracers from the CSF into the PVS of the 
brain surface and brain parenchyma. Finally, we attempted 
to confirm whether an influx of tracers through the arterial 
PVS could be demonstrated under in vivo anesthetized con-
ditions using through-skull near-infrared (NIR) imaging or 
by magnetic resonance imaging (MRI).
Materials and methods
Mice
Female C57BL/6J-Tyrc-J albino or C57BL/6J wild type mice 
(Jackson Laboratories, Bar Harbor, ME) and Prox1-GFP 
[12] and SMMHC-GFP [55] reporter mice on C57BL/6J 
backgrounds were kept under specific pathogen–free con-
ditions and used for experimental studies at the age of 
2–3 months. All mouse experiments were approved by 
Kantonales Veterinaramt Zurich (license numbers 185/13, 
196/13 and 161/16) and by the Landesamt für Gesundheit 
und Verbraucherschutz, Saarbruecken, Germany (license 
number: 15/2017), and performed following the regulations 
of the Swiss Federal Welfare Act (TSchG) and the European 
legislation on the protection of animals (Directive 2010/63/
EU).
Studies of CSF outflow during awake or anesthesia 
conditions
At 20 min before intracerebroventricular (i.c.v.) infusion, 
0.1 mg/kg buprenorphine was injected subcutaneously. Mice 
were anesthetized by intraperitoneal injection of 80 mg/kg 
ketamine and 0.2 mg/kg medetomidine or inhalation of 2% 
isoflurane and fixed in a stereotaxic frame (RWD, San Diego, 
CA). For the awake group, lateral ventricle tracer infusion 
(as described below) was performed under 2% isoflurane 
and the mice were allowed to recover (within 5–10 min after 
infusion) and were awake for 60 min before imaging. Mice 
were observed to be active and behaving normally. For the 
isoflurane group, tracer infusion was performed under 2% 
isoflurane and the mice were kept anesthetized under 2% iso-
flurane for 60 min on a heating pad (37 °C) before imaging. 
For the ket/med group, 80 mg/kg ketamine and 0.2 mg/kg 
medetomidine were injected intraperitoneally before tracer 
infusion and the mice were kept anesthetized for 60 min on 
a heating pad (37 °C) before imaging. About 2 min before 
imaging at the saphenous vein, mice from the awake and iso-
flurane groups were given 80 mg/kg ketamine and 0.2 mg/
kg medetomidine intraperitoneally. Mice were first imaged 
for the blood signal at the saphenous vein, then overdosed by 
intraperitoneal injection of 400 mg/kg ketamine and 1 mg/
kg medetomidine for post-mortem imaging.
Infusion of tracers into the lateral ventricle
The skull was thinned with a dental drill (RWD) at a loca-
tion 0.95 mm lateral and 0.22 mm caudal to the bregma. A 
34 G steel needle was inserted into the right lateral ventricle 
2.35 mm ventral to the skull surface. For the standard pro-
tocol, 2.5 µL of 200 μM P40D680 or P40D800 [43] tracer 
at the speed of 1 µL/min was then infused with a syringe 
pump (Stoelting, Wood Dale, IL). For determination of the 
outflow dynamics in response to different volume infusions, 
alternate protocols involving 1.0 µL of 500 μM P40D680 
at 0.4 µL/min and 5.0 µL of 100 μM P40D680 at 2 µL/min 
were used. The needle was left in place for 2.5 min and then 
slowly removed while observing if any significant backflow 
occurred. After tracer infusion, the injection hole in the 
skull was filled with bone wax (Ethicon, Somerville, NJ) 
and the scalp was sutured, except when in vivo through-
skull imaging was subsequently carried out. Animals were 
excluded if significant backflow occurred or ex vivo analysis 
of brain slices indicated that the injection of tracer into the 
ventricle was not successful. For experiments where ven-
tricular infusion was followed by dynamic contrast-enhanced 
MRI imaging, an identical protocol was used with the fol-
lowing modifications: 2.5 µL of a Gadospin D solution at 
25 mM gadolinium (nanoPET Pharma GmbH, Germany) 
was infused instead of P40D680, a 33 G steel needle was 
used in combination with a NanoJet syringe pump (Chemyx, 
Stafford, CT) and the needle was left in place after infusion 
for 5 min.
Infusion of tracers into the cisterna magna
Mice were anesthetized by intraperitoneal injection of 
80 mg/kg ketamine and 0.2 mg/kg medetomidine, fixed in 
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a stereotaxic frame (Kopf, Tujunga, CA) and the body tem-
perature was maintained at 37 °C using a heating pad. A sur-
gical procedure to access the cisterna magna was performed 
[30]. After a small skin incision over the occipital bone/cer-
vical spinal cord was made, the three covering muscle layers 
were carefully dissected under a stereomicroscope using fine 
forceps and scissors. A beveled glass capillary micropipette 
(Sutter instruments, Novato, CA, USA) with a diameter 
of < 60 μm was made using a Sutter P97 Pipette puller (Sut-
ter instruments) and was positioned perpendicular to the 
ear bars and advanced to penetrate the dura until resistance 
was overcome, indicating entry into the cisterna magna as 
previously described [2]. Overall, 5 µL of a Gadospin D 
solution at 25 mM gadolinium (nanoPET Pharma GmbH) 
was infused at the speed of 1 µL/min with a NanoJet syringe 
pump (Chemyx). After the infusion, the micropipette was 
left in place for 10 min to avoid reflux. Following its with-
drawal, the wound was closed.
NIR imaging of CSF lymphatic transport to systemic 
blood
For noninvasive imaging of tracer signals in blood [37], fur 
above the saphenous vein region was removed with a razor 
and depilation cream before the i.c.v infusion. At the desired 
time point after i.c.v. infusion, mice were anesthetized with 
ket/met as described above. Mice were then positioned under 
a Zeiss StereoLumar.V12 stereomicroscope with AxioVi-
sion software (Carl Zeiss, Feldbach, Switzerland) and a Pho-
tometrics Evolve 512 camera (Photometrics, Tucson, AZ) 
in a supine position on a heating pad (37 °C) for imaging. 
The autofluorescence signal on the GFP channel was used 
to position the saphenous blood vessels at 64 × zoom. An 
image under the Cy5 filter was acquired with exposure time 
and camera gain settings of 200 ms and 200, respectively.
For dynamic imaging of tracer outflow to blood with dif-
ferent infusion rates, mice were positioned within 5 min after 
the completion of infusion under the stereomicroscope as 
above. Dynamic imaging was initiated 5 min after the com-
pletion of the ventricle infusion by acquisition of a sequence 
of images (1 image every 15 s for 55 min) with a Cy5 filter 
set to monitor the NIR signal of the saphenous vein. Expo-
sure time and camera gain settings were 200 ms and 200, 
respectively.
Assessment of lymphatic transport to blood
Using AxioVision software, a circular region of inter-
est (ROI) of radius 100 μm was placed over the saphenous 
vein on the acquired images. The mean signal intensity was 
then recorded within this region. For quantification of sig-
nal enhancement, tissue background signals were subtracted 
using the mean values from three uninjected mice with the 
same image acquisition settings.
For the dynamic imaging, a table of fluorescence intensity 
in counts versus time was exported into Microsoft Excel 
using the measure profile function. Since there was a slight 
loss of signal at the beginning of the scans due to photo 
bleaching of tissue autofluorescence, baseline intensity in 
counts was calculated as an average signal of the lowest ten 
consecutive imaging frames. This baseline intensity was 
then subtracted from the fluorescence intensity values in 
order to plot fluorescent signal enhancement versus time in 
min. The transport time to blood was determined as the point 
at which signal enhancement value was 100 counts above 
baseline levels.
Analysis of tracer distribution on the brain surface 
and in CNS‑draining lymph nodes
Images of P40D680 tracer spread on the surfaces of the brain 
and within the deep cervical and mandibular lymph nodes 
were acquired with a Zeiss AxioZoom V16 microscope and 
a QImaging OptiMOS sCMOS camera (QImaging, Surrey, 
Canada) combined with a light-emitting diode illumination 
system pE-4000 (CoolLED Ltd, Andover, UK) and ZEN 
2 software (Carl Zeiss, Feldbach, Switzerland). In excised 
brains, images were acquired over the contralateral dorsal 
hemisphere (20 × , 20 ms exposure) and of the entire ven-
tral side of the brain (11.2 × , 200 ms exposure). Images of 
lymph nodes were acquired in situ at 25 × and 200 ms expo-
sure time. Since there were no apparent differences in signal 
in the lymph nodes on the injected and contralateral sides, 
the average value of the nodes from each side was used. 
For quantification of signal enhancement, tissue background 
signals were subtracted using the mean value from three 
uninjected mice with the same image acquisition settings.
In vivo imaging through the skull
After i.c.v. tracer infusion, the mouse was transferred to the 
microscope and the head fixed in a stereotactic frame on 
a heating pad (37 °C). The skull was kept hydrated with 
warmed PBS under a glass coverslip, and dynamic imaging 
of the contralateral half of the brain was carried out for a 
maximum of 60 min after tracer infusion through the skull 
of the anesthetized mouse using a Zeiss StereoLumar.V12 
stereomicroscope (as described above). Dynamic imaging 
through the skull was carried out with a gain of 300 and 
an exposure time of 50 ms (Cy5 filter for P40D680 tracer) 
or 200 ms (ICG filter for P40D800 tracer). In some cases, 
imaging was continued during administration of an overdose 
of 400 mg/kg ketamine and 1 mg/kg medetomidine (i.p.), or 
after an overdose with ketamine/medetomidine followed by 
transcardiac perfusion with ice-cold PBS.
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For determination of CSF dynamics, circular ROIs of 
1 mm diameter were placed over the location of the con-
tralateral lateral ventricle and over the location of the quadri-
geminal cistern in the acquired video using ImageJ/FIJI. Sig-
nal intensity within these ROIs was determined over time.
Magnetic resonance imaging
Animals were examined in a horizontal-bore 9.4 T animal 
scanner (BioSpec Avance III 94/20; Bruker Biospin GmbH, 
Ettlingen, Germany) with a BGA12S gradient system with 
ParaVision 6.0.1 (Bruker Biospin GmbH) and a linearly 
polarized coil with an inner diameter of 40 mm (Bruker 
Biospin GmbH). Imaging was performed with a three-
dimensional time of flight gradient recalled echo sequence 
(3D-TOF-GRE) originally adapted for imaging of peripheral 
lymph vessels [41] with recovery time of 12.0 ms, echo time 
of 2.5 ms, flip angle  25o, matrix 600 × 400 × 180, field of 
view 36.00 mm × 25.92 mm × 18.00 mm, zero fill 2, 1 aver-
age and a scan time of 4 min 19 s 200 ms. Signal intensity 
(SI) reduction in blood vessels was achieved by placement 
of a saturation slice over the mouse heart.
Three-dimensional maximum intensity projection (MIP) 
reconstructions, SI and noise measurements were performed 
with ParaVision 6.0.1 (Bruker Biospin GmbH). For SI 
analysis, ROIs were created manually in a single slice per 
measurement, 1 mm dorsal to the circle of Willis. For SI 
measurements in cortical parenchyma and noise determi-
nation from background SI, identically sized circular ROIs 
were employed, while cortical tissue containing vessels was 
segmented manually (see Supplemental Fig. 4).
For animals in which injection of MRI contrast medium 
was not successful (wrong location of the injection or signif-
icant backflow from the injection site), MR imaging experi-
ments were discontinued.
Brain sections
Mouse brains were dissected and fixed in 4% PFA at 4 °C for 
48 h. A section of the brain between 1 mm rostral and 1 mm 
caudal to the needle insertion site was cut out by razor blade. 
Coronal sections were made from dorsal to ventral side at 
a thickness of 100 µm with a vibratome (Leica VT1000 S). 
Images were acquired with a Zeiss AxioZoom V16 micro-
scope and ZEN 2 software.
Analysis of tracer influx into the brain parenchyma
The percentage area of tracer coverage in brain sections 
was determined using ImageJ/FIJI as follows. The cerebral 
cortex was selected as an ROI on images of coronal brain 
sections. A uniform threshold was applied to all images, 
and background signal manually erased. The percentage 
area coverage of the signal within the ROI was determined. 
Analysis of all images was independently carried out in a 
blinded manner by two investigators, and an average was 
taken of six coronal sections per mouse.
The deepest tracer penetration within the dorsal cerebral 
cortex was determined using lines drawn perpendicular to 
the brain surface with ImageJ/FIJI. The two largest values 
were taken for the injected and contralateral sides, and an 
average of these four values was taken for six sections per 
mouse by two independent investigators. Due to clear dif-
ferences between images from perfused and non-perfused 
brains, blinding was not feasible for this analysis.
Statistics
Mice were randomly allocated to different experimental 
groups. Group sizes were estimated based on pilot studies 
to determine the success rate and reproducibility of the intra-
ventricular infusions. All data are presented as mean ± SD. 
Means of two groups were compared using an unpaired two-
tailed Student’s t test. Means of three groups were compared 
with one-way ANOVA with the Tukey’s multiple compari-
son post hoc test. Correlation analysis was done using Pear-
son’s correlation. All analyses were performed using Graph-
Pad Prism V5.0 (GraphPad Software, San Diego, CA) and 
p < 0.05 was accepted as statistically significant.
Results
Outflow of CSF increases during awake conditions
Using dynamic near-infrared fluorescence imaging, we have 
previously demonstrated that CSF-infused tracers reach 
the systemic circulation in anesthetized mice by transport 
through the lymphatic system rather than via a direct out-
flow from the subarachnoid space to venous blood [37]. 
With this in mind, we first aimed to determine the levels 
of CSF-injected tracer that reached the systemic blood in 
mice that were allowed to wake after i.c.v. infusion versus 
mice that were maintained under anesthesia. As shown in the 
experimental design scheme in Fig. 1a, three groups of mice 
were assessed for CSF transport to blood at 60 min after 
lateral ventricle infusion of a 40 kDa bulk flow tracer [37]. 
Two groups of mice were infused with 2.5 µL of 200 µM 
P40D680 over the course of 2.5 min under isoflurane anes-
thesia. After suture of the skin above the skull, mice in the 
awake group were allowed to recover and move normally 
within the cage, while mice in the isoflurane group were 
maintained on a heating pad under isoflurane. At 60 min 
after the i.c.v. infusion, both groups of mice were injected 
with ketamine/medetomidine (ket/med) for in vivo imag-
ing of tracer signal within the saphenous vein. A third 
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group (ket/med group) was kept under ket/med anesthesia 
for the duration of the infusion, maintenance and imaging 
procedures.
Using a fluorescence stereomicroscope, imaging of 
P40D680 signal within the saphenous vein indicated that 
mice from the awake group had significantly increased tracer 
levels within the systemic blood at 60 min compared to mice 
that were maintained under either anesthetized condition 
(Fig. 1b-c). The tracer levels at 60 min in awake mice cor-
responded to 62.9 ± 10.9% of the i.c.v infused tracer present 
Fig. 1  CSF outflow is increased during awake conditions. a Scheme 
of experimental design for quantification of CSF outflow during 
awake or anesthesia conditions. Before imaging at the saphenous 
vein, mice from awake and isoflurane group were given 80 mg/kg ket-
amine, 0.2 mg/kg medetomidine intraperitoneally. After imaging, all 
mice were overdosed with 400 mg/kg ketamine, 1 mg/kg medetomi-
dine. b Representative images of saphenous bundle of blood vessels 
at 60 min post-infusion of P40D680 into lateral ventricle. Scale bar: 
500 µm. c Quantification of P40D680 signal in the blood 60 min after 
tracer i.c.v. infusion. d Scheme indicating ROI and ex vivo imaging 
of the basal aspect of the brain at 60 min post-infusion showing pres-
ence of P40D680 tracer at circle of Willis and cisterns. Blue polygon 
in upper left image represents the analyzed ROI. Scale bar: 2000 µm. 
e Quantification of P40D680 signal at basal cisterns 60  min after 
infusion
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within the blood when compared to the fluorescent signals 
in mice that were intravenously injected with the same dose 
(20,149 ± 3490 vs. 32,018 ± 718 counts). After killing the 
mice via ket/med overdose and harvesting the brains, we 
compared the signals of P40D680 that remained at the basal 
cisterns around the circle of Willis as another measure of 
CSF clearance (Fig. 1d). As expected, mice in the awake 
group had significantly less P40D680 remaining at 60 min 
compared to mice that were under either type of anesthe-
sia (Fig. 1e). These results indicate that clearance of CSF-
infused tracers is increased during awake conditions, con-
sistent with our findings of enhanced lymphatic clearance 
during awake conditions in other regions of the body [44].
Dynamics of CSF outflow support lymphatic efflux
Since a significant portion of the injected dose quickly 
reaches the systemic blood in the awake mice, we aimed 
to provide support that CSF outflow occurs through lym-
phatic vessels under these conditions. As live monitoring of 
the dynamics of tracer transport to systemic blood in awake 
mice is not feasible, we killed mice at four different time 
points (15, 30, 60 and 90 min) after i.c.v. infusion to assess 
tracer levels in the blood, the basal cisterns and the CNS-
draining lymph nodes. We compared the signals in mice that 
were allowed to wake to signals from mice that had been 
infused and maintained under ket/med (Fig. 2a), conditions 
where we have previously demonstrated that CSF tracer out-
flow occurs predominantly through a lymphatic route [37].
At 15 min after i.c.v. infusion, tracers were already pre-
sent at low levels in systemic blood in the awake group, but 
the signals were not above background levels in the ket/med 
group (Fig. 2b). The signals in blood increased over time 
in both groups and were 5.7-fold higher at 30 min, 3.0-fold 
higher at 60 min and 1.8-fold higher at 90 min in awake 
mice compared to ket/med mice. The signal intensity at the 
basal cisterns showed an opposite pattern with significantly 
lower levels of tracer remaining at 30, 60 and 90 min in the 
awake group (Fig. 2c). Intensity of the signals in the CNS-
draining deep cervical and mandibular lymph nodes imaged 
in situ at 15 min showed higher levels in the awake group; 
however, no significant differences between the two groups 
were apparent at 30 min (Fig. 2d–f). At 60 and 90 min, the 
levels of tracer in both deep cervical and mandibular lymph 
nodes in awake mice were significantly lower than those in 
ket/med mice, consistent with the observation that most of 
the infused tracer in the awake mice had already reached the 
systemic blood.
As further evidence for lymphatic clearance of CSF under 
awake conditions, we next aimed to demonstrate a time point 
shortly after recovery from anesthesia at which signals could 
be found within the lymphatic system but not yet in the sys-
temic blood. This was challenging as blood signals were 
already elevated at the 15 min time point in the awake group, 
as shown in Fig. 2b. We speculated that a reduced infu-
sion rate and volume may slow down the dynamics of CSF 
outflow, which has been shown to be dependent on intrac-
ranial pressure [9, 23, 39]. To test this, we infused into the 
lateral ventricle identical doses of P40D680 but at different 
volumes and rates. This led to clear effects on the transport 
to blood with a delay in the transport time when the lowest 
volume was infused (Supplementary Fig. 1a, b). Therefore, 
we infused 1 µL of 500 µM P40D680 and killed the mice at 
10 min after i.c.v. infusion, shortly after the mice had awak-
ened (Supplementary Fig. 1c). As shown in the representa-
tive mouse in Supplementary Fig. 1d, using this protocol we 
could not detect tracer within the bloodstream (above the 
assay sensitivity of 0.2% of the infused dose [37]), but found 
that tracer was readily detected in the collecting lymphatic 
vessels and draining lymph nodes by 10 min after tracer 
infusion (Supplementary Fig. 1e). In sum, these dynamic 
imaging results support the conclusion that CSF clearance 
occurs rapidly through lymphatic vessels in mice during 
awake conditions.
Distribution of tracers to the PVS is inversely 
correlated with CSF outflow
Glymphatic (paravascular) influx of CSF-injected tracers 
into the brain has been found to be reduced in awake mice 
compared to those under sleeping or anesthetized conditions 
[54]. Therefore, we next assessed whether the rapid tracer 
efflux from the CSF that we observed during awake condi-
tions could affect the spread of the tracers to the PVS of the 
brain surface and the parenchyma of the brain. Similar to the 
levels of tracer intensity demonstrated in the basal cisterns 
(Fig. 1d), there were obvious differences in the amount of 
tracer located within PVS on the dorsal brain surface and 
parenchyma of the brain (Fig. 3a, b). Mice anesthetized 
with ket/med demonstrated an increased signal intensity on 
the surface of the brain, with a clear PVS pattern observed, 
compared to mice that were awake (Fig. 3c). Mice under 
isoflurane anesthesia showed an intermediate pattern of 
tracer spread. The PVS within the brain parenchyma also 
presented with significantly increased tracer signal in the 
ket/med group compared to mice in the isoflurane and awake 
groups (Fig. 3d).
We then pooled the data from mice analyzed under all 
three conditions at the 60 min time point and performed 
correlation analyses to determine whether there were any 
significant relationships between the tracer levels within the 
blood, at the basal cisterns and within the PVS of the brain 
surface. These analyses showed clearly that the spread of 
tracer to the PVS of the brain surface was directly related 
to the amount of tracer remaining at the basal cisterns and 
157Acta Neuropathologica (2019) 137:151–165 
1 3
Fig. 2  Dynamics of outflow support CSF drainage through lymphatic 
vessels. a Scheme of experimental design for quantification of the 
dynamics of CSF outflow during awake or ket/med anesthesia condi-
tions. b Quantification of P40D680 signals in the blood. c Quantifi-
cation of P40D680 signals at basal cisterns. d Representative in situ 
images of deep cervical LNs at 15, 30, 60 and 90 min post-infusion 
of P40D680 into lateral ventricle. Scale bars: 1000 µm. e Quantifica-
tion of P40D680 signals in the deep cervical lymph nodes (LNs). f 
Quantification of P40D680 signals in the mandibular LNs
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indirectly proportional to the amount that had reached the 
systemic blood (Fig. 3e). These findings support the concept 
in which rapid outflow of CSF-administered tracers observed 
during awake conditions limits the distribution of tracers to 
the PVS (Supplementary Movie 1).
Tracers accumulated within PVS of the brain surface 
around both arteries and veins, even at early time 
points
Close examination of the surface of the brain at 60 min indi-
cated that tracers were found not only along brain surface 
arteries, but also along veins (Supplementary Fig. 2a). We 
confirmed this using a SMMHC-GFP reporter mouse where 
Fig. 3  Spread to paravascular space (PVS) is inversely correlated 
to CSF outflow. a Representative images of tracer-filled PVS on the 
brain surface of the dorsal hemisphere contralateral to the infusion 
site. Scale bars: 1000 µm. b Representative images of tracer accumu-
lation in PVS around penetrating vessels on 100  µm brain sections. 
Scale bars: 1000 µm. c Quantification of P40D680 signal on the brain 
surface 60 min after infusion. d Quantification of P40D680 signal in 
the cortex of the 100 µm brain sections 60 min after infusion. e Cor-
relations from all mice examined at 60  min demonstrating relation-
ships between signals at basal cisterns, brain surface and systemic 
blood. All quantifications are normalized to signals in n = 3 unin-
jected mice
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contractile arterial smooth muscle cells (SMC) show green 
fluorescence. The tracer was localized outside the SMC lay-
ers of the arteries (Supplementary Fig. 2b), consistent with a 
“paravascular” rather than a “perivascular” or “intramural” 
location as defined by Engelhardt et al. [18]. Surprisingly, 
even in mice that were killed only 2 min after the completion 
of the infusion into the ventricles, we were able to detect the 
presence of tracer along branches of the caudal rhinal veins 
(Supplementary Fig. 2c). In these mice, there was no obvi-
ous tracer penetration into the parenchyma; therefore, the 
tracer spread from PVS of arteries to veins did not appear 
to be occurring within the brain (Supplementary Fig. 2d). 
These results indicate that pathways for CSF flow may exist 
between the PVS of arteries and veins at the brain surface.
Through‑skull in vivo imaging demonstrates spread 
of tracers within the PVS of large‑caliber vessels 
of the brain surface
We hypothesized that the spread of tracers within the PVS of 
the brain surface in mice anesthetized with ket/med might be 
demonstrated in vivo using NIR imaging through the intact 
skull. To establish this assay, we infused P40D800 tracer into 
the right lateral ventricle and imaged over the left cortical 
hemisphere through the skull of the mouse with a NIR-sen-
sitive fluorescence stereomicroscope (Fig. 4a). The longer 
wavelength P40D800 tracer exhibits similar properties to the 
P40D680 tracer but allows NIR imaging with better depth 
penetration and lower tissue autofluorescence. When imag-
ing was initiated at 20 min post i.c.v. infusion, tracer signals 
emanating from the lateral ventricles and cisternal spaces of 
CSF, such as the quadrigeminal cistern, were seen (Fig. 4b). 
Fig. 4  Tracer spread from the CSF is limited to PVS of surface blood 
vessels in  vivo. a Schematic illustration of setup for in  vivo near-
infrared imaging through the skull. b Representative images of tracer 
spread along brain surface blood vessels visualized through the skull 
20, 40 and 60  min after infusion of 2.5  µL 200  μM P40D800 into 
the contralateral ventricle. Scale bars: 1000 μm. Dotted circles show 
1 mm diameter ROIs used for quantification of tracer signal from lat-
eral ventricle and quadrigeminal cistern. c Quantification of fluores-
cence signal from the lateral ventricle (blue) and quadrigeminal cis-
tern (black) after tracer infusion as in (b) (n = 5). Data show mean 
(solid lines) ± SD (dashed lines). d–e Close-ups of region shown in 
(b) with corresponding autofluorescence images  60  min after tracer 
infusion indicating tracer spread along large surface arteries (A) and 
transfer to surface veins (V). Scale bars: 500 μm
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Quantification of videos of these regions over time showed 
an expected loss of signal from the ventricles concurrent 
with an increasing signal from the CSF in the quadrigeminal 
cistern (Supplementary Movie 2, Fig. 4c). During this time, 
tracer signals became apparent along the middle cerebral 
artery (MCA) and its branches and slowly spread within the 
network of PVS around these vessels (Fig. 4b, d). In some 
mice, we could observe a spread of tracer from the PVS of 
the branches of the MCA to some of the larger veins such as 
the dorsal middle cerebral and dorsal rostral cerebral veins 
(Supplementary Movie 3, Fig. 4e). However, at no point in 
time was it obvious that there was a spread of tracer from 
the larger brain surface arteries to the penetrating arteries 
entering the cortex. Therefore, we conclude that under our 
in vivo experimental conditions, the spread of tracer over 
the dorsal hemisphere is confined to the large caliber arteries 
and veins at the brain surface.
Rapid paravascular spread of tracers into the brain 
parenchyma after death
Our imaging experiments revealed discrepancies between 
in  vivo and ex  vivo patterns of tracer within the PVS. 
In vivo, the tracer-filled spaces appeared wider [5], there 
was a more limited spread to the PVS over the dorsal hemi-
spheres and there was no obvious penetration of tracers 
along cortical blood vessels despite being clearly evident 
on brain sections (Fig. 3b). Therefore, we speculated that 
a post-mortem artifact might be present that could explain 
these differences.
To test this, we acquired videos through the skull of mice 
before and during an overdose with ket/med. Mice were 
imaged in vivo until 60 min after tracer infusion, at which 
point the tracer spread was limited to the larger surface ves-
sels, especially the MCA (Fig. 5a, b, Supplementary Movie 
Fig. 5  Extensive post-mortem tracer spread on brain surface and to 
penetrating blood vessels. a–h Images of tracer spread visualized 
after infusion of 2.5 µL 200 μM P40D800 into the contralateral ven-
tricle. Imaging through the skull (a–g) or after skull removal (h). a 
Autofluorescence image of brain region imaged. b Tracer spread 
60 min after infusion of 2.5 µL 200 μM P40D800 into the contralat-
eral ventricle. c Tracer spread after overdose with ket/med i.p. but 
before last breath. d Tracer spread 1  min after last breath. e Tracer 
spread 1.5 min after last breath suggesting constriction of arteries ini-
tiating from the MCA. f Tracer spread 2 min after last breath showing 
spreading of arterial constriction to smaller branches of the MCA. g 
Tracer spread 8 min after last breath showing spreading to penetrating 
blood vessels. h Imaging of tracer spread after skull removal indicat-
ing that signal detection was not significantly obstructed by imaging 
through the skull. i Images of tracer spread in brain of SMMHC-GFP 
mouse ex vivo 60 min after infusion of 2.5 µL 200 μM P40D800 into 
the lateral ventricle. SMMHC-GFP positive vessels (green) mark 
arteries with contractile smooth muscle cells. Circles indicate loca-
tion of tracer (white) at penetrating blood vessels. Scale bars: 500 μm
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4). We then overdosed the animal via i.p. injection of a lethal 
dose of ket/med. During the next few minutes, there was a 
minimal further spread of tracer while the animal exhibited 
gasping activity (Fig. 5c). Immediately after the final breath 
was taken, a wave was seen to spread through the cortex 
that originated laterally with vasoconstriction of the large 
branches of the MCA and spread medio-dorsally over the 
surface of the cortical hemisphere (Supplementary Movie 4). 
Following this wave, there was an advance of tracer towards 
the smaller branches of the MCA and the penetrating arter-
ies, as well as to the venous PVS (Fig. 5d–g). Comparison 
of the images from the same mice before and after skull 
removal clearly demonstrated that the images acquired 
through the skull revealed the true extent of tracer spread 
(Fig. 5h). Notably, tracer signal at the penetrating vessels 
was only apparent after death (Fig. 5i).
We next confirmed that an influx to the PVS was occur-
ring after death using MRI. Infusions of a macromolecular 
contrast agent, Gadospin D, were performed into either the 
cisterna magna or the right lateral ventricle and a series of 
three-dimensional MRI datasets was then acquired with a 
T1-weighted sequence. After a period of approximately 
40 min, one group of mice (n = 5) was overdosed with ket/
med while a control group (n = 5) was maintained under 
Fig. 6  Spread of contrast agent 
to PVS after death as detected 
with MRI. a Visualization of 
tracer spread after infusion of 
5 µL of a Gadospin D solution 
at 25 mM gadolinium into the 
cisterna magna; data acquired 
with a series of T1-weighted 
MRI measurements (three-
dimensional time of flight gradi-
ent recalled echo sequence). 
MIP images on the upper panel 
show a mouse that was kept 
alive under ket/med anesthesia 
and showed no spread of the 
tracer towards the PVS. The 
bottom panel images show 
a mouse that was overdosed 
with ket/med; the time of death 
is indicated as t = 0. Strong 
enhancements of signal are 
detectable 9 min after death at 
the circle of Willis (CoW) and 
at the middle cerebral artery 
(MCA). Smaller branches of the 
MCA are clearly visible 27 min 
after death. b, c Quantification 
of signal-to-noise ratio (SNR) 
after tracer infusion in the cis-
terna magna in mice kept under 
ket/med anesthesia (n = 5) or in 
mice killed by ket/med overdose 
(n = 5). Regions of interests 
were defined on the surface of 
the cortex (b) and the cortical 
parenchyma (c). SNR values 
were normalized to the time of 
death and set to time = 0. Data 
show mean ± SD. d Compari-
son of the slopes calculated by 
linear regression of SNR over 
time for the surface of the cor-
tex and for cortical parenchyma 
in the control group and in the 
group of mice killed by ket/med 
overdose
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ket/med anesthesia. Clear enhancements of signal occurred 
at the circle of Willis and the MCA after death that was 
not apparent in the control groups (Fig. 6a, Supplementary 
Fig. 3, Supplementary Movies 5 and 6). Next, we performed 
quantification in mice that were infused through the cisterna 
magna since they did not have interfering signals from the 
ventricles. Signal-to-noise ratio measurements were made 
using ROIs on the surface of the cortex (assumed to be 
PVS) and the cortical parenchyma (Supplementary Fig. 4). 
After normalization of the signals to the time of death (set 
to time = 0), these assessments revealed that the slope of 
the signal increase was significantly greater in both regions 
after death when compared to the control mice (Fig. 6b–d). 
Importantly, no detectable influx of contrast agent occurred 
in the parenchyma of the in vivo control group at any point 
after infusion.
We also tested whether cardioperfusion would limit the 
spread of tracers to the parenchyma at the time of death. Vid-
eos acquired immediately after the completion of perfusion 
demonstrated that the spread of tracers was also occurring 
post-mortem under these conditions (Supplementary Movie 
7). Assessment of the influx depth of tracer spread in the 
PVS of the parenchyma demonstrated no difference between 
mice killed by overdose or via cardioperfusion (Supplemen-
tary Fig. 5). We conclude that shortly after death a signifi-
cant spread of tracer occurs through the PVS of the larger 
surface vessels to the PVS of the parenchyma.
Discussion
In this study, we demonstrated using intraventricular infu-
sions of a bulk flow tracer and fluorescence stereomicros-
copy that CSF outflow was increased in awake mice com-
pared to anesthetized mice. Evaluation of the dynamics of 
this outflow supports the conclusion that CSF clearance 
occurs through the lymphatic system in this species. An 
inverse relationship was found between the efflux of CSF 
to the systemic blood and the spread of CSF tracers to the 
paravascular spaces as assessed ex vivo. In vivo imaging of 
PVS spread of tracers at the brain surface demonstrated that 
this spread was limited to the PVS of larger caliber arteries 
and veins. Finally, we found that a rapid influx of tracers to 
the PVS of the cortical parenchyma occurred just after the 
death of the animal.
A substantial increase in the outflow of CSF tracers to 
the systemic blood in awake mice was found compared to 
mice that were anesthetized. There is very little similar data 
to compare to regarding this point, although one previous 
report demonstrated increased CSF clearance of radiolabeled 
tracer from the spine in active compared to resting subjects 
[17]. It is likely that physical activity affects CSF pressure 
and increases flow towards efflux pathways. Respiration and 
arterial pulse are driving forces for CSF flow and mixing 
[16, 20] and the rates of both are naturally higher in awake 
versus anesthetized animals. These results also lend further 
support for a CSF outflow pathway that is predominantly 
lymphatic in nature [9, 37]. Lymphatic clearance is highly 
dependent on muscular activity and transport through lym-
phatic vessels is dramatically increased when the subject is 
awake [22, 44, 49]. The concept of lymphatic rather than 
venous outflow of CSF still remains to be rigorously evalu-
ated in humans, however, some evidence does exist to sup-
port this pathway in non-human primates and cadavers [31, 
38].
An increased CSF outflow while awake is not fully con-
sistent with the concept of increased CSF flushing through 
the brain during sleep or deeply anesthetized conditions 
[54]. In the glymphatic model, CSF within the arterial PVS 
serves as an input fluid to the brain. If the CSF turnover is 
rapid during awake conditions, this would limit access of 
CSF-infused tracers to the PVS, a factor that was not consid-
ered during the original study [25, 54]. Another recent MRI 
study has challenged the concept that increased glymphatic 
flow occurs in anesthetized mice compared to awake mice 
[21]. However, this study concluded that CSF influx was 
actually increased during awake conditions, which we have 
not found to be the case. It is unclear whether the tracer that 
was measured in the brain by MRI in vivo was intravascu-
lar after effluxing the CSF to reach the systemic circulation 
rather than a direct influx into the parenchyma from CSF 
as proposed by the authors. In addition, the low-molecular 
weight tracer used in this study as well as other recent MRI 
studies [7, 34, 47] would exhibit significant concentration 
gradient-dependent diffusion into the brain parenchyma and 
thus would not accurately demonstrate the bulk flow path-
ways of CSF.
It is important to note that it was not our aim to assess 
sleeping, unanesthetized mice with our methods, nor have 
we monitored clearance of tracer injected into the paren-
chyma. Therefore, theoretically, an increased clearance of 
metabolites from the brain might indeed occur under sleep-
ing conditions. The destination for the efflux fluid in the 
glymphatic model is not exactly clear; one version of the 
model shows fluid exiting through the PVS around veins 
to reach the CSF while another proposes that there may be 
connections to lymphatic vessels within the dura mater [4, 
28, 35, 36]. However, we were unable to demonstrate any 
paravascular influx of CSF into the brain during anesthetized 
in vivo conditions and we have found significantly increased 
clearance of CSF under waking conditions. Therefore, at this 
point, it is difficult to imagine how an increased brain flush-
ing during sleep via a bulk CSF influx through the glym-
phatic system could be occurring as originally envisaged.
The close correlation between signals in the basal cisterns 
and the PVS of the brain surface highlights the circle of 
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Willis as an important potential access point for CSF and its 
components into the PVS. The circle of Willis is the main 
source of the arteries that feed into the brain. A recent study 
in rats has confirmed an earlier observation that stomata 
exist in the pia mater covering these arteries which may 
provide anatomical pathways for CSF and macromolecules 
from the basal cisterns to the PVS [42, 56]. The major CSF 
outflow routes along several cranial nerves [37] (e.g., olfac-
tory, optic, trigeminal) are located immediately rostral to the 
circle of Willis, indicating that CSF flow could be directed 
either out of the skull or into the arterial PVS depending on 
the physiological conditions.
Our data support the concept that some portion of CSF 
can spread to the brain surface PVS in vivo, at least under 
anesthetized conditions where there is reduced CSF outflow. 
We have also observed a spread of tracer from the PVS of 
arteries to the PVS of veins on the brain surface, consistent 
with the recently published concept of low resistance path-
ways for CSF flow at this location [6]. It will be interesting 
to examine at an anatomical level whether connections are 
present between the leptomeningeal sheaths of the PVS of 
arteries and veins. CSF may also spread along the large ves-
sels that penetrate from the ventral aspect into the brain, 
such as into the midbrain as shown in MRI studies [15]. 
A recent MRI study in humans has shown that the diffu-
sion of a low molecular weight contrast agent into the brain 
parenchyma correlated with the availability of the contrast 
agent in the surrounding CSF [47]. Thus, a dynamic balance 
between CSF turnover and CSF solute distribution to the 
brain may exist that could be altered under different physi-
ological or pathological conditions.
The most surprising finding of this study was a major 
influx of tracer into the PVS that occurred immediately after 
the death of the animal. This observation was predicted by 
the prominent neuroscientist Lewis Weed who wrote in 1914 
that “ordinarily, after death, cerebrospinal fluid is aspirated 
by the brain” [53]. One might expect that the substantial 
loss of blood pressure that occurs within the brain at death 
would establish a gradient for flow from the CSF to the brain 
parenchyma [53]. Thus, quantifications of tracer that are per-
formed within the PVS or parenchyma of the brain ex vivo 
are likely overestimates of the levels that are present in vivo. 
This phenomenon may also account for some of the previous 
findings based on ex vivo assessments that have concluded 
that CSF influx was occurring into the brain within minutes 
of tracer administration [2, 8, 45, 52].
In sum, our data support the conclusion that a bulk flow 
of CSF into the brain along the PVS likely does not occur 
under physiological conditions and that the rate of outflow 
of CSF is a major factor determining whether substances 
within CSF can spread to the brain. This work may have 
important implications in drug delivery to the CNS after 
intrathecal administration and in several conditions that may 
lead to altered CSF flow dynamics such as traumatic brain 
injury and stroke.
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